U.S. Direct Anterior Approach Market Research Report – Forecast to 2027

U.S. Direct Anterior Approach (Total Hip Replacement) Market in ACS Market Research Report, by U.S. Total Hip Replacement Market, U.S. Total Hip Replacement by DAA, U.S. Total Hip Replacement Market for DAA by ACS - Global Forecast Till 2027

ID: MRFR/HC/4725-CR | July 2018 | Region: Global | 100 pages         

U.S. Direct Anterior Approach (Total Hip Replacement) Market

The U.S. direct anterior approach (total hip replacement) in ASC market is anticipated to touch a valuation of USD 1,793.2 million and experience a 13.6% CAGR during the assessment period (2020-2027)

Segmentation

By Type S. Total Hip Replacement by DAA S. Total Hip Replacement Market for DAA by ASC

Key Players

  • Smith & Nephew
  • Proliance Surgeons
  • OrthAlign Inc.
  • Bone & Joint Surgery Clinic
  • Center for Special Surgery
  • Stryker Corporation
  • Orthoillinois
  • Zimmer Biomet
  • Johnson & Johnson Services Inc. (DePuy Synthes)
  • The Hip and Knee Center

Drivers

  • The high demand for hip reconstruction products
Speak to Analyst Request a Free Sample

The U.S. direct anterior approach (total hip replacement) in ASC market is anticipated to touch a valuation of USD 1,793.2 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is likely to experience a 13.6% CAGR during the assessment period (2017-2023) owing to the high prevalence of osteoarthritis.  The rise in numbers of the geriatric populace is another factor expected to positively impact the market. According to the United States Census Bureau, nearly 42.6 million are above the age of 65 and the number will rise sharply by 2030.


Osteoarthritis is one of the prime reasons for aggravating hip pain in the elderly. Direct anterior approach (DAA) is a minimally invasive surgery made possible with a small incision without cutting any tendons. This technique has benefits such as low surgery time, reduced post-surgery pain, and rapid recovery of the patient. But high costs of total hip arthroplasty (THA) or total hip replacement can hamper market growth.


Report Overview


This report allows the user to gain a deeper understanding of the ongoing events and trends in the U.S. market for direct anterior approach. By correlating the historical data with key market dynamics, our analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the U.S. direct anterior approach in ASC market segmented by type filled with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.


Segment Overview


By service, the U.S. direct anterior approach in ASC market has been segmented into U.S. total hip replacement, U.S. total hip replacement by DAA, and U.S. total hip replacement for DAA by ASC. The U.S. THA for DAA by ASC segment is anticipated to register a remarkable growth rate during the forecast period owing to shorter and inexpensive stays in ambulatory surgery centers (ASC) as compared to hospitals. The U.S. total hip replacement segment is touted to reach a valuation of USD 15,990.5 million by 2023.


For the scope of research, the standard definition of the product/service “direct anterior approach (total hip replacement)” is included in the report. The report discusses and interprets the current and future opportunities of the industry by delivering an unbiased growth assessment.


Players Covered


Smith & Nephew, Proliance Surgeons, OrthAlign, Inc., Bone & Joint Surgery Clinic, Center for Special Surgery, Stryker Corporation, Orthoillinois, Zimmer Biomet, Johnson & Johnson Services Inc. (DePuy Synthes), The Hip and Knee Center, and others are noteworthy players in the U.S. direct anterior approach (total hip replacement) in ASC market. These players are investing in research and development (R&D) to launch new products on an annual basis. For instance, Zimmer Biomet increased their R&D budget to develop new techniques such as the anterior supine intermuscular THA.


The report offers comprehensive profiles on these market players and assesses their current standing in the U.S. direct anterior approach in ASC market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, mergers and acquisitions (M&A) activities, and latest R&D initiatives are outlined in the report.


Research Methodology


Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers, studying statistics published by reputed government agencies, and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report comprises news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.


Analysis Period



  • Base Year - 2016

  • Projection Period - From 2017 to 2023

  • Market Denomination - USD Million

  • Conversion Rate - Considered as per the respective financial years


For the scope of research, the report offers a comprehensive analysis of the U.S. direct anterior approach in ASC market .


Type



  • S. Total Hip Replacement Market

  • S. Total Hip Replacement by DAA

  • S. Total Hip Replacement Market for DAA by ASC


Intended Audience



  • Potential investors

  • Hospitals and Clinics

  • Government Associations

  • Pharmaceutical & Biotechnology Industries

  • Research Institutes

  • Suppliers and Distributors

  • Raw Material Suppliers



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The projected CAGR for US Direct Anterior Approach Market would be 13.6% during the forecast period.

The expected valuation of US Direct Anterior Approach Market would be USD 1793.2 million.

The segments included in the process are the lateral approach, the direct anterior approach, and a posterior approach.

The challenges would be the high cost of the process and complicated procedure.

The players are Zimmer Biomet, Stryker, Johnson and Johnson Services Inc. (DePuy Synthes), and Smith & Nephew.

U.S. Direct Anterior Approach (Total Hip Replacement) Market in ACS: Competitive Landscape


Smith & Nephew, Zimmer Biomet, Stryker and Johnson & Johnson Services Inc. collectively accounted for more than 79.8% of the market share of the U.S. Direct Anterior Approach (Total Hip Replacement) Market in 2017. These companies continue to retain their strong market presence through expansions, mergers and acquisitions, and extensive product portfolio.


In 2017, Johnson & Johnson Services, Inc. (DePuy Synthes) was the leading player in the market and accounted for more than ~33.3% of market share. The large share of the company is attributed to the high demand for hip reconstruction products. Moreover, this company has a strong sales and distribution network. Along with that, this company also provides after sales services which play a major role in the satisfaction of the customers.


Zimmer Biomet held the second position in the market and accounted for more than ~26.6% of the market share. Zimmer Biomet has a vast product portfolio in the total hip replacement industry. The company also has a wide geographic presence as it operates in various countries all around the world. It has a significant presence in North America, Europe, and the Middle East and Africa, with commercial, manufacturing, and research facilities in more than one dozen countries.


Stryker held the third position in terms of market share, in 2017 and accounted for more than ~11.8% of the market share. The company follows the strategy of launching new products and focuses on the acquisition and collaboration with an aim to minimize the competition. For instance, in 2018, Stryker launched Trident Acetabular System, made up of its tritanium in growth technology. Tritanium mimics the porous bone and thus enhances cell attachment and proliferation which eventually promotes long-term biologic fixation.


Smith & Nephew acquired the fourth spot in the market. The company is well known for its sports medicine, trauma, orthopedic reconstruction, and advanced wound management. In 2015, Smith & Nephew announced the acquisition of Blue Belt Holdings, Inc. for USD 275 million, making the company secure a leading position in the fast-growing area of orthopedic robotics-assisted surgery.


New product developments along with the strategy of acquisitions is a key focus area for players as the demand for more effective products continues to grow. Majority of the companies have adopted the strategy of acquisitions and product launches for the market development.